Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Liqiong Xue"'
Autor:
Junli Xue, Liqiong Xue, Wenbo Tang, Xiaoxiao Ge, Wei Zhao, Qun Li, Wei Peng, Congqi Dai, Ye Guo, Jin Li
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background: Immune checkpoint inhibitor therapy has demonstrated impressive clinical benefits in multiple tumor types. TQB2450, a novel monoclonal antibody targeting programmed cell death ligand 1, has shown safety and efficacy in preclinical studies
Externí odkaz:
https://doaj.org/article/557397a0f2a9422393d63f4dde0231ef
Autor:
Liqiong Xue, Wenbo Tang, Jiuli Zhou, Junli Xue, Qun Li, Xiaoxiao Ge, Fengjuan Lin, Wei Zhao, Ye Guo
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundThis study aimed to identify potential biomarkers in patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) and further probe the prognostic implications of CDKN2A mutations, particularly within a subset receivi
Externí odkaz:
https://doaj.org/article/2a433fc70d1e4749a14eb4fe75cc9a2f
Autor:
Xu Liang, Junli Xue, Xiaoxiao Ge, Jin Li, Huiping Li, Liqiong Xue, Lijun Di, Wenbo Tang, Guohong Song, Qun Li, Hanfang Jiang, Wei Zhao, Fengjuan Lin, Bin Shao, Xiugao Yang, Zhufeng Wu, Tianyi Zhang, Chenchen Wang, Ye Guo
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Bone metastases are common complications of solid tumors. The outcome is poor despite major progress in cancer therapies. We describe a multicenter, open-label, phase 1, dose escalation and expansion trial of JMT103, a novel fully humanized receptor
Externí odkaz:
https://doaj.org/article/d9f8a5d623704ee7bb333d91fe8fce07
Autor:
Liqiong Xue, Hongzhu Yan, Ying Chen, Qifa Zhang, Xin Xie, Xiaoying Ding, Xiaojing Wang, Zhongqing Qian, Feng Xiao, Zhiyi Song, Yijie Wu, Yongde Peng, Huanbai Xu
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background The incidence of papillary thyroid carcinoma (PTC) has been increasing worldwide in recent years. Therefore, novel potential therapeutic targets for PTC are urgently needed. Enhancer of zeste homolog 2 (EZH2), a methyltransferase
Externí odkaz:
https://doaj.org/article/2c8b48d9135446c5afac69341462ba99
Publikováno v:
EBioMedicine, Vol 44, Iss , Pp 375-386 (2019)
Background: Emerging evidence suggests that metabolic alterations are a hallmark of cancer cells and contribute to tumor initiation and development. Cancer cells primarily utilize aerobic glycolysis (the Warburg effect) to produce energy and support
Externí odkaz:
https://doaj.org/article/cab961d5c2b3415ba078677b5702fd5f
Publikováno v:
Journal of Immunology Research, Vol 2020 (2020)
Externí odkaz:
https://doaj.org/article/c644de47dcbc4d4e9e56d6a0ce5087b9
Publikováno v:
Journal of Immunology Research, Vol 2019 (2019)
Colorectal cancer (CRC) remains the third most commonly diagnosed cancer, ranking second among the most common causes of cancer-related mortality. Immune checkpoint therapy has recently been shown to have great potential. However, only some patients
Externí odkaz:
https://doaj.org/article/d3894d3fb198472a980b719857db1c75
Autor:
Liqiong Xue, Chunming Pan, Zhaohui Gu, Shuangxia Zhao, Bing Han, Wei Liu, Shaoying Yang, Shasha Yu, Yixuan Sun, Jun Liang, Guanqi Gao, Xiaomei Zhang, Guoyue Yuan, Changgui Li, Wenhua Du, Gang Chen, Jialun Chen, Huaidong Song
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e84514 (2013)
In our previous studies, we presumed subtypes of Graves' disease (GD) may be caused by different major susceptibility genes or different variants of a single susceptibility gene. However, more evidence is needed to support this hypothesis. Single-nuc
Externí odkaz:
https://doaj.org/article/e4393e699c4844aeb859e2cba0a709af
Autor:
Miao-Zhen Qiu, Yang Zhang, Ye Guo, Wei Guo, Weiqi Nian, Wangjun Liao, Zhongyuan Xu, Wenxue Zhang, Hong-Yun Zhao, Xiaoli Wei, Liqiong Xue, Wenbo Tang, Yunteng Wu, Guoxin Ren, Ling Wang, Jingle Xi, Yongshuai Jin, Hu Li, Chaohong Hu, Rui-Hua Xu
Publikováno v:
JAMA oncology. 8(7)
The antibody drug conjugate drug MRG003 comprises an anti-epidermal growth factor receptor (EGFR) humanized immunoglobulin G1 monoclonal antibody that is conjugated with monomethyl auristatin E via a valine-citrulline linker. There is currently insuf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::162adcdde5cf9d81f9afbd9a571836e7
https://pubmed.ncbi.nlm.nih.gov/35511148
https://pubmed.ncbi.nlm.nih.gov/35511148
Autor:
Rui-Jia Zhang, Yan Li, Bing Han, Liqiong Xue, Huai-Dong Song, Lele Zhang, Man-Man Zhang, Feng Sun, Jin Wu, Cuixia Zheng, Guanbiao Zhou, Ya Fang
Publikováno v:
Aging (Albany NY)
Lung cancer is the leading cause of cancer death worldwide and accounts for more than one-third of all newly diagnosed cancer cases in China. Therefore, it is of great clinical significance to explore new driver gene mutations in non-small-cell lung
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::497920ffabc3edb88a01e2241daacbda
https://doi.org/10.18632/aging.103500
https://doi.org/10.18632/aging.103500